Boulmpou, A.; Moysiadis, T.; Zormpas, G.; Teperikidis, E.; Vassilikos, V.; Giannakoulas, G.; Papadopoulos, C.
Exploring the Feasibility of Integrating Cardiopulmonary Exercise Testing, Echocardiography, and Biomarkers for Predicting Atrial Fibrillation Recurrence: Rationale, Design and Protocol for a Prospective Cohort Study (The PLACEBO Trial). J. Clin. Med. 2025, 14, 1690.
https://doi.org/10.3390/jcm14051690
AMA Style
Boulmpou A, Moysiadis T, Zormpas G, Teperikidis E, Vassilikos V, Giannakoulas G, Papadopoulos C.
Exploring the Feasibility of Integrating Cardiopulmonary Exercise Testing, Echocardiography, and Biomarkers for Predicting Atrial Fibrillation Recurrence: Rationale, Design and Protocol for a Prospective Cohort Study (The PLACEBO Trial). Journal of Clinical Medicine. 2025; 14(5):1690.
https://doi.org/10.3390/jcm14051690
Chicago/Turabian Style
Boulmpou, Aristi, Theodoros Moysiadis, Georgios Zormpas, Eleftherios Teperikidis, Vassilios Vassilikos, Georgios Giannakoulas, and Christodoulos Papadopoulos.
2025. "Exploring the Feasibility of Integrating Cardiopulmonary Exercise Testing, Echocardiography, and Biomarkers for Predicting Atrial Fibrillation Recurrence: Rationale, Design and Protocol for a Prospective Cohort Study (The PLACEBO Trial)" Journal of Clinical Medicine 14, no. 5: 1690.
https://doi.org/10.3390/jcm14051690
APA Style
Boulmpou, A., Moysiadis, T., Zormpas, G., Teperikidis, E., Vassilikos, V., Giannakoulas, G., & Papadopoulos, C.
(2025). Exploring the Feasibility of Integrating Cardiopulmonary Exercise Testing, Echocardiography, and Biomarkers for Predicting Atrial Fibrillation Recurrence: Rationale, Design and Protocol for a Prospective Cohort Study (The PLACEBO Trial). Journal of Clinical Medicine, 14(5), 1690.
https://doi.org/10.3390/jcm14051690